Cisplatin as second-line therapy in ovarian carcinoma treated initially with single-agent paclitaxel: a Gynecologic Oncology Group study

Author: Thigpen J.T.   Blessing J.A.   Olt G.   Lentz S.S.   Bell J.  

Publisher: Elsevier

ISSN: 0090-8258

Source: Gynecologic Oncology, Vol.90, Iss.3, 2003-09, pp. : 581-586

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content